Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant, its candidate treatment for Cushing’s syndrome. The setback cast doubt on CORT’s pipeline strength and triggered a sharp re-evaluation by analysts. It underscores the market’s sensitivity to regulatory developments in small-cap drug makers.
Over 40 countries have started implementing sweeping new rules that seek to make crypto taxes more transparent and harder to avoid. According to a Financial Times report, crypto exchanges in the UK will now be required to collect complete details of user activity and report it to HM Revenue & Customs under global rules developed
Logan Mohtashami, a senior HousingWire analyst, believes mortgage rate stability – not rate cuts – will be the key driver for the US housing market in 2026. While many focus on the Fed policy, Mohtashami told CNBC today that the real story actually lies in whether mortgage rates can hold steady near 6% next year.
On December 1st, famed investor Jim Cramer looked into the camera on CNBC’s Mad Money and made a provocative statement – “maybe the stretched consumer is a false narrative.” At first glance, the statement seemed to fly in the face of conventional wisdom. For months, headlines have been dominated by “vibe-cession” talks, the impact of
Analysts increasingly believe Microsoft could reach a $5 trillion market valuation in early 2026. The analysis is driven by accelerating artificial intelligence monetisation, dominance in enterprise cloud infrastructure, and expanding operating margins that are reshaping the company’s earnings trajectory. Currently valued at approximately $3.59 trillion as of late December 2025, Microsoft would need a 41%
India’s financial ecosystem in 2025 was shaped less by headline-grabbing launches and more by consolidation across payments, lending, and trade finance. Digital rails expanded further into daily economic activity, regulatory frameworks stabilised after a period of churn, and lenders increasingly relied on data-driven models to assess risk. At the same time, persistent constraints around liquidity,
As 2025 draws to a close, one of the cryptocurrency’s standout stories must be Zcash (ZEC) and its outperformance as the privacy coin narrative took hold. ZEC’s explosion, marked by a staggering jump from lows of $60 in late September to near $700 in mid-November, thrust privacy-focused digital assets into the spotlight. Key catalysts have
Looking ahead to 2026, Bitcoin price forecasts present a sharp divide between institutional optimism and cautionary signals from historical chart patterns. While major banks and crypto-native firms continue to predict higher prices driven by structural shifts in the market, technical indicators suggest the risk of a prolonged drawdown remains significant. Institutional forecasts temper optimism Following
Biotech stocks have staged an impressive rally over the past six months, with the XBI index – key benchmark for small and mid-cap biotech names – posting one of its strongest stretches on record. Mizuho’s senior healthcare analyst Jared Holz believes this momentum is more than a short-term bounce. Speaking with CNBC, he argued the
In a dramatic turn of events shaking the cryptocurrency world, Neo co-founders Da Hongfei and Erik Zhang have entered a public dispute over the blockchain’s governance and financial management, highlighting critical questions about decentralisation and transparency. First reported by Wu Blockchain on December 15, 2024, the conflict exposes deep divisions within one of the leading